31 December 2009

Contents

Editorial

• Volume 10 Number 11/12 November/December 2009

Conference reports

• 12th European AIDS Society Conference (EACS) 11-14 November 2009, Cologne

• EACS releases three updated management guidelines (December 2009)

• 11th International Workshop on Adverse Drug Reactions and Comorbidities in HIV (IWADR) 26-28 October 2009, Philadelphia

• Intermuscular tissue is decreased in HIV infection

• High incidence and risk factors for diabetes in French cohort

• Gender and race differences in lipodystrophy symptoms

• Lipodystrophy is common in children from three European cohorts

• Visceral adipose tissue returns to baseline after stopping therapeutic intervention with rHGH

• Reduced levels of vitamin D in patients taking efavirenz

• Association between inflammation and sleep apnea in the MACS cohort

• Sports supplements impact on serum creatinine and eGFR markers of renal function

• 9th AIDS Vaccine Conference 19-22 October 2009, Paris

• Thai HIV Vaccine Trial results presented and published

• 49th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 12-15 September 2009, San Francisco

• Smoking masks the long-term benefits of HAART on lung function

• Recent ARVs and the blood/brain barrier: CSF drug concentrations of darunavir/r and raltegravir

• Raltegravir body composition study: 48-week DEXA results

• Alcohol and marijuana may reduce drug levels of atazanavir and efavirenz

• Other drug interaction studies at ICAAC